mTOR, translation initiation and cancer
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Control of mRNA translation plays a fundamental role in many aspects of cell metabolism. It constitutes a critical step in the control of gene expression, and consequently cell growth, proliferation and differentiation. Translation is regulated in response to nutrient availability, hormones, mitogenic and growth factor stimulation and is coupled with cell cycle progression and cell growth. Signaling by the PI3K/Akt/mTOR pathway profoundly affects mRNA translation through phosphorylation of downstream targets such as 4E-BP and S6K. Inhibitors of this pathway and thus cap-dependent translation are emerging as promising therapeutic options for the treatment of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such a shift has been associated with proliferation in tumorigenesis, and has been linked to the translational control of RPs (Mamane et al., 2006; Ruggero and Sonenberg, 2005).”
From Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes (2011) · cites this paper as Mamane et al., 2006
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · cited 5×
“…factors and hormones) with aminoacid availability and intracellular energy status to control translation rates and additional metabolic processes (Hay and Sonenberg, 2004) (Figure 2). mTOR has received considerable attention, as rapamycin (Rapamune) is a specific inhibitor of mTOR activity (for…”
BackgroundInfluentialSelf-citationExploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185 · cited 1×
“An important downstream target of this signaling pathway is cap-dependent mRNA translation (Hay and Sonenberg, 2004; Hennessy et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the…”
BackgroundeIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121 · cited 4×
“The cap structure, m7GpppN (where N is any nucleotide), is present at the 50 terminus of all cellular eucaryotic mRNAs (except those in organelles) (Gingras et al., 1999b).”
BackgroundInfluentialSelf-citationRegulation of 4E-BP1 phosphorylation: a novel two-step mechanism
Gingras, A.-C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,343 · cited 4×
“The cap structure, m7GpppN (where N is any nucleotide), is present at the 50 terminus of all cellular eucaryotic mRNAs (except those in organelles) (Gingras et al., 1999b).”
BackgroundInfluentialSelf-citationHolz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Pause, A., Belsham, G. J., Gingras, A.-C., Donzé, O., Lin, T.-A., Lawrence, J. C., & Sonenberg, N. (1994) · Nature · doi:10.1038/371762a0 · Cited by 1,239 · cited 1×
“…Heat and Acid-Stable protein regulated by Insulin) and 4E-BP2, were identified in a screen using radiolabelled recombinant eIF4E protein to probe a human placenta expression library (Pause et al., 1994) and by sequencing the complementary DNA (cDNA) clone for PHAS-I (Hu et al., 1994).”
BackgroundSelf-citationMammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 1×
“Enhancement of the eIF4E/4E-BP interaction, through the expression of a constitutively active 4E-BP mutant (all phosphorylation sites mutated to Ala), leads to a decrease in cell size and inhibition of cell cycle progression in a manner that mimics rapamycin treatment (Fingar et al., 2002, 2004).”
BackgroundKim, D.-H., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K. V. P., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 961 · cited 1×
“…et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the 4E-BPs (Gingras et al., 2001; Jacinto and Hall, 2003; Kim et al., 2003; Ruggero and Pandolfi, 2003; Kim and Sabatini, 2004).”
BackgroundMalignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956 · cited 1×
“…binding (Gingras et al., 1999b). eIF4G recruits the 40S small ribosomal subunit to the mRNA through the ribosomeassociated eIF3. eIF4E eIF4E was the first translation factor shown to cause malignant transformation when overexpressed in cul- tured rodent cells (Lazaris-Karatzas et al., 1990).”
BackgroundSelf-citationSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951 · cited 1×
“Furthermore, two groups independently demonstrated that eIF4E promotes lymphomagenesis in cooperation with Myc in transgenic mice (Ruggero et al., 2004; Wendel et al., 2004).”
Background
Cited by
Items 501–600 of 618
Autosomal Dominant Polycystic Kidney Disease and Inherited Cystic Diseases
Somlo, S., Torres, V. E., & Caplan, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50084-x · Cited by 6
Determinants of pancreatic tropism in metastatic renal cell carcinoma
Xu, H., Kapur, P., Christie, A., Nielsen, A. W., Perny, A., Brandenburg, O., Small, C., Miyata, J., Zhong, H., Roberts, C., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.195195 · Cited by 4
“* P < 0.05, *** P < 0.001, and **** P < 0.0001 by Fisher’s exact test or the Fisher-Freeman-Halton exact test, as appropriate. used as a surrogate (27, 28).”
InfluentialGao, X., Li, J., Feng, X., Xie, Y., Zhang, J., Liu, P., Wang, B., & Liu, P. (2024) · The FASEB Journal · doi:10.1096/fj.202401919r · Cited by 4
“22,23 While the AKT/mTOR pathway is recognized as an upstream regulator of HIF2 α , whether it can regulate HIF2 α to promote breast cancer metastasis remains largely unknown.”
Immunohistochemical evaluation of the mTOR pathway in intra‐oral minor salivary gland neoplasms
Diamanti, S., Nikitakis, N. G., Rassidakis, G. Z., Doulis, I., & Sklavounou, A. (2016) · Oral Diseases · doi:10.1111/odi.12504 · Cited by 4
Autosomal Dominant Polycystic Kidney Disease
Somlo, S., Torres, V. E., & Caplan, M. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00080-x · Cited by 4
He, W., Cheng, Z., Huo, Z., Lin, B., Wang, X., Sun, Y., Yu, S., Cao, S., Xue, J., Liu, R., et al. (2023) · Endocrinology · doi:10.1210/endocr/bqac215 · Cited by 5
Wilson, F. A., Orellana, R. A., Suryawan, A., Nguyen, H. V., Jeyapalan, A. S., Frank, J. W., & Davis, T. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90253.2008 · Cited by 16
“Phosphorylation of 4E-BP1 leads to the disassociation of eIF4E from 4E-BP1, allowing eIF4E to associate with eIF4G to form, in conjunction with eIF4A, the active eIF4F complex (36), which mediates the binding of mRNA to the 40S ribosomal subunit (23).”
BackgroundInfluentialViral Vectors for Treatment of Human Disease: Therapeutic and Manufacturing Challenges
Diallo, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00007-1 · Cited by 4
Temisorlimus in the treatment of advanced renal cell carcinoma
Escudier, B. J. (2007) · Oncology Reviews · doi:10.1007/s12156-007-0009-2 · Cited by 3
Pioglitazone does not improve insulin signaling in mice with GH over-expression
Gesing, A., Bartke, A., & Masternak, M. M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0124 · Cited by 3
“It is known that hormones (including insulin), growth factors, and other mitogens activate the PI3K/AKT/mTOR signaling cascade (Mamane et al. 2006).”
mTORC1: Upstream and Downstream
Yao, Y., Parnell, N., & Inoki, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30035-9 · Cited by 3
DDX3X acts as a selective dual switch regulator of mRNA translation in acute ER stress
Shawky, A.-E.-M., Eckhardt, A. V., Mick, J. B., Dondeti, M. F., Avanzino, K., Simintiras, C. A., Hatzoglou, M., & Vourekas, A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116493 · Cited by 2
mTOR signaling in liver disease
Cornu, M., de Coquereaumont, G. D. C., & Hall, M. N. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch22 · Cited by 3
Tuberin-heterozygous cell line TSC2ang1 as a model for tuberous sclerosis-associated skin lesions
Wlodarski, P. K., Maksym, R., Ołdak, M., Jóźwiak, S., Wójcik, A., & Jóźwiak, J. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.2.245 · Cited by 2
Catalytic mammalian target of rapamycin inhibitors as antineoplastic agents
Mohindra, N. A., & Platanias, L. C. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1026816 · Cited by 2
Molecular Genetic Markers in Female Reproductive Cancers
Wang, T., Davidson, B., Buckhaults, P., Huang, C., & Pohl, G. (2010) · Journal of Oncology · doi:10.1155/2010/307460 · Cited by 2
Li, L., Zhang, L., Liu, D., Cheng, Y., Jing, Y., Yu, H., Zhou, P., Song, J., & Li, W. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12196 · Cited by 2
Savinska, L. O., Klipa, O., Khoruzhenko, A., Shkarina, K., Garifulin, O. M., & Filonenko, V. V. (2015) · Biopolymers and Cell · doi:10.7124/bc.0008ee · Cited by 2
Weighing up the possibilities: Controlling translation by ubiquitylation and sumoylation
Watts, F. Z., Baldock, R. A., Jongjitwimol, J., & Morley, S. (2014) · Translation · doi:10.4161/trla.29211 · Cited by 4
Courtneidge, S. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50005-1 · Cited by 2
Kim, J. M., & Lee, H. W. (2017) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2017.49.4.470 · Cited by 1
“…and the p-S6 activity was moderate in the CRAC and HIN. signaling proteins and cancer has been actively conducted in various fields, It deals specifically with cell signaling and its relevance to various cancers and the usefulness of drugs to block overexpressed cellular signaling proteins [8-12].”
microRNA miR‐315‐5p regulates developmental growth in Drosophila wings by targeting S6k
Lee, T., Kim, C. J., Lim, D., & Lee, Y. S. (2025) · Insect Science · doi:10.1111/1744-7917.70027 · Cited by 1
“Activation of TOR leads to the phosphorylation of ribosomal protein kinase p-70-S6k (S6k) and the translation initiation factor 4E-binding protein (4E-BP), promoting protein synthesis (Inoki et al. , 2005; Mamane et al. , 2006).”
Ruffolo, B., Vicente-Muñoz, S., Mehta, K. Y., Rivera‐Cruz, C. M., Zhao, X., Romick‐Rosendale, L. E., Setchell, K. D. R., Lane, A., & Wells, S. I. (2025) · Cancers · doi:10.3390/cancers17152583 · Cited by 1
“To identify potential effectors of this phenotype, we examined the mTOR pathway, a well-established driver of translation in cancer [49], which is known to phosphorylate 4E-BP1 and ribosomal protein S6 to enhance translation efficiency [50].”
Zhang, C., Li, Y., Zhang, W., Ma, T., Li, X., Guo, Y., Zhang, L., Ding, X., & Hu, D. (2025) · Animal Bioscience · doi:10.5713/ab.250773 · Cited by 1
Mutational Activation of KRAS and BRAF in Colorectal Cancer
Pedone, K. H., Sells, J. L., & Der, C. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8412-7_5 · Cited by 1
Quand le fil de l’ARN messager s’entortille et bloque sa traduction…
Marzi, S., Romby, P., & Klaholz, B. P. (2007) · médecine/sciences · doi:10.1051/medsci/20072310881 · Cited by 1
“Présentation des références Appelées dans le texte par leurs numéros entre crochets ([1], [2], [3-5]) et classées par ordre d’apparition dans l’article.”
Oronsky, B. T., Oronsky, A. L., Lybeck, M., Oronsky, N. C., Scicinski, J. J., Carter, C. A., Fanger, G. R., & Reid, T. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00016-3 · Cited by 1
Elia, A., Powley, I. R., MacFarlane, M., & Clemens, M. J. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0061 · Cited by 2
Regulation and dysregulation of protein synthesis in cancer cells
Clemens, M. J., Elia, A., & Morley, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.007 · Cited by 1
Cardiac Plasticity in Health and Disease
Gondalia, R., Rothermel, B. A., Lavandero, S., Gillette, T. G., & Hill, J. A. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_7 · Cited by 1
Bostner, J. (2013) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-100903 · Cited by 1
“The translation initiation factors are then free to form a complex and start the translation of specific proteins, such as c-myc [182].”
BackgroundProspects for mTOR targeting in adult T cell leukemia
Altman, J. K., & Platanias, L. C. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190902741505 · Cited by 1
Wilson, F. A., Suryawan, A., Orellana, R. A., Nguyen, H. V., Jeyapalan, A. S., Gazzaneo, M. C., & Davis, T. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90423.2008 · Cited by 2
“Disassociation of eIF4E from 4EBP1 allows for the formation of the active eIF4G eIF4E complex (37).”
BackgroundInfluentialTamoxifen: Mechanisms of resistance
Adams, C. M. (2010) · doi:10.21007/etd.cghs.2010.0004
“AKT can also indirectly activate mTOR which also controls cell growth, survival, and apoptosis [76].”
BackgroundThe influence of miR-99a on mTOR signaling regulation in colorectal cancer cell lines.
Rice, J. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2412 · Cited by 1
Response to Letter to the Editor: Metformin in colorectal cancer: A match ruled by MiR26b?
Linkevičiūtė-Ulinskienė, D., Dulskas, A., Patašius, A., Zabulienė, L., Urbonas, V., & Smailytė, G. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101626 · Cited by 1
Liu, X., Zeng, S., Liu, S., Wang, G., Lai, H., Zhao, X., Bi, S., Guo, D., Chen, X., Yi, H., et al. (2020) · doi:10.21203/rs.3.rs-15752/v1 · Cited by 1
“However, the family of 4ebps can inhibite the assembly of eIF4F complex [45].”
BackgroundThe Genetic Profiles of TIF1 and TIF2 Duplicate Genes
Venturi, V. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16999348.v1 · Cited by 2
Matthes, A., Ouibrahim, L., Lecampion, C., Caranta, C., Davanture, M., Lebrun, R., Couté, Y., Baudet, M., Meyer, C., & Robaglia, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.16.528822 · Cited by 1
Binet, R. (2011) · theses.fr (ABES) · doi:10.70675/916d8908z8aa1z4f8czb709z8963a6a3752c · Cited by 3
Regulation of Growth by Drosophila FoxO Transcription Factor
Mattila, J. (2009) · Helda - University of Helsinki Institutional Repository
Regulation of autophagy and mTOR during Semliki Forest virus infection
Eng, K. E. (2012) · Figshare
To Translate or Degrade: Cytoplasmic mRNA Decision Mechanisms
Beisang, D. J., & Bohjanen, P. R. (2014) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201300011
O'Callaghan, C., & Patricia, O. (2011) · InTech eBooks · doi:10.5772/26349
“Moreover, increased levels and/or phosphorylation of downstream targets of mTORC1 have been reported in various human malignancies in which they correlate with tumour aggressiveness and poor prognosis (Guertin & Sabatini, 2007; Mamane et al., 2006).”
Investigating the role of SUMOylation of eukaryotic translation initiation factors
Jongjitwimol, J. (2015) · UPT. Syiah Kuala University Library (Syiah Kuala University)
The mechanism of signal transduction by the GPI anchored Prod 1 protein
Blassberg, R. A. (2010) · UCL Discovery (University College London)
The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview
Koropouli, E., Manolopoulos, L., Pandha, H., & Syrigos, K. (2009) · Current Enzyme Inhibition · doi:10.2174/157340809787314274
“[24] Mamane, Y.”
Analysis of FOXO transcriptional networks
van der Vos, K. E. (2007) · Utrecht University Repository (Utrecht University)
Fougeray, S. (2012) · theses.fr (ABES) · doi:10.70675/f71bbcabz6bacz4424z9870z8589cbef3e54 · Cited by 3
“Le niveau d’expression de l’ARNm de p62 et l’expression protéique de p62 sont augmentés, respectivement, dans des tumeurs pulmonaires et dans des cellules murines transformées avec une oncoprotéine (Nezis and Stenmark, 2012).”
BackgroundInfluentialEstudo do controle traducional de PPAR durante o processo de diferenciação de macrófagos
Cambiaghi, T. D. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2010.tde-25032010-145009 · Cited by 2
“Na ausência destes estímulos, a proteína S6K1 se associa ao fator eIF3, inibindo-o [Mamane et al., 2006].”
BackgroundRegulation of Growth Factor and Nutrient Sensing Pathways by Human Papillomavirus E6 Proteins
Spangle, J. M. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Theaflavins stimulate autophagic degradation of a-synuclein in neuronal cells
Sekiyama, K., Nakai, M., Fujita, M., Takenouchi, T., Waragai, M., Wei, J., Sekigawa, A., Takamatsu, Y., Sugama, S., Kitani, H., et al. (2012) · Open Journal of Neuroscience
DNA Viruses and Cancer: Taking a Broader Look
Alwine, J. C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0016-5_6
Moore, J. (2015) · Brock University Digital Repository (Brock University)
Molecular analysis of combined mTOR/HDAC inhibition in multiple myeloma
Gamache, B. (2013) · Figshare · doi:10.57912/23868024
The Critical Role of PI3K-AKT-mTOR Pathway for IL-15 Induced NK Cell Effector Responses
Nandagopal, N. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3860
“This kinase activity of mTORC1 is specifically blocked by 31 the drug rapamycin (Mamane et al., 2006).”
BackgroundSwerdlow, S. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Shaltouki, A. (2011) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Alterations in the regulatory networks of cellular and molecular events
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.005
Novel targets of eiF2 kinases determine cell fate during the integrated stress response
Baird, T. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1883
Dual mTOR/HDAC Inhibition: Preclinical Development of a Novel Breast Cancer Therapy
Yevtushenko, M. A. (2013) · Dominican Scholar (Dominican University of California) · doi:10.33015/dominican.edu/2013.bio.05
“In mammals there are two ribosomal S6 kinases, S6K1 and S6K2, whose activation is regulated by mTOR [23-25].”
BackgroundLiberal, M., & Jesús, J. (2016) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Etude des mécanismes d'actions de SuperMApo dans un modèle de sclérose en plaques
Gauthier, T. (2017) · theses.fr (ABES) · doi:10.70675/74d53243zcab9z4229z84daz8104a6a1200e
VIRAL REGULATION OF CAP-DEPENDENT MESSENGER RNA TRANSLATION INHIBITOR 4E-BP1 DURING MITOSIS
Velásquez, C. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Chun, S. Y. (2018) · Deep Blue (University of Michigan)
A participação da via fosfatidilinositol3-quinase (PI3K)/mTOR no carcinoma epidermoide oral
Duarte, A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-20072018-092758
Mitchell, D. C. (2019) · Deep Blue (University of Michigan)
Abdullahi, A., Olaleke, B., Adeyemi, R. O., & Oluwatosin, S. (2020) · Journal of Emerging Technologies and Innovative Research
Miller, K. (2019) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Animal model of cirrhosis with hepatocellular carcinoma : a reliable tool for testing new therapies.
Kurma, K. (2019) · theses.fr (ABES) · doi:10.70675/c1f57d75z1627z4572zab2ez85a87e7dbe5e
Charest, P. G. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717956615.793461222
García‐Sastre, A. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1123432.582895
Proliferative signaling pathways in hepatocellular carcinoma
Madhamanchi, P., Madhamanchi, K., Peela, S., Rao, P. M., Bramhachari, P. V., & Phanithi, P. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98807-0.00021-1 · Cited by 2
y Cajal, S. R., Sesé, M., Armengol, G., & Aasen, T. (2015) · Springer eBooks · doi:10.1007/978-3-662-46875-3_2282
The balance between survival and apoptosis
Fabregat, I. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6826-3_25
y Cajal, S. R., Sesé, M., Armengol, G., & Aasen, T. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_2282-3
Pettersson, U. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737326194.793573085
Armengol, G., & y Cajal, S. R. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_2282
Armengol, G., & y Cajal, S. R. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_2282
mTORC1: Upstream and Downstream
Yao, Y., & Inoki, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00182-6
Cancer bronchique primitif, voies de signalisation intra-cellulaires et modèles précliniques
Mordant, P. (2012) · theses.fr (ABES) · doi:10.70675/73c809e8z63fcz4cb7z9db7z202520b1918b
Shor, B., Zhang, W., Toral‐Barza, L., Lucas, J., Abraham, R. T., Gibbons, J. J., & Yu, K. (2023) · doi:10.1158/0008-5472.c.6497649
Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma
O'Reilly, K. E., Warycha, M. A., Davies, M. A., Rodrik-Outmezguine, V. S., Zhou, X. K., Yee, H. T., Polsky, D., Pavlick, A. C., Rosen, N. X., Bhardwaj, N., et al. (2023) · doi:10.1158/1078-0432.c.6517965
Data from Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
Chiong, E., Lee, I.-L., Dadbin, A., Sabichi, A. L., Harris, L. D., Urbauer, D. L., McConkey, D. J., Dickstein, R. J., Cheng, T., & Grossman, H. B. (2023) · doi:10.1158/1078-0432.c.6519434
Wangpaichitr, M., Savaraj, N., Maher, J. C., Kurtoğlu, M., & Lampidis, T. J. (2023) · doi:10.1158/1535-7163.c.6532089
Kuo, W., Liu, J., Mauceri, H. J., Vokes, E. E., Weichselbaum, R. R., Rosner, M. R., & Cohen, E. E. W. (2023) · doi:10.1158/1535-7163.c.6531572
Yoshizawa, A., Fukuoka, J., Shimizu, S., Shilo, K., Franks, T. J., Hewitt, S. M., Fujii, T., Cordon‐Cardo, C., Jen, J., & Travis, W. D. (2023) · doi:10.1158/1078-0432.c.6518590
Kuo, W., Liu, J., Mauceri, H. J., Vokes, E. E., Weichselbaum, R. R., Rosner, M. R., & Cohen, E. E. W. (2023) · doi:10.1158/1535-7163.c.6531572.v1
Johansson, G., Mahller, Y. Y., Collins, M. H., Kim, M., Nobukuni, T., Perentesis, J. P., Cripe, T. P., Lane, H. A., Kozma, S. C., THOMAS, G. V., et al. (2023) · doi:10.1158/1535-7163.c.6531741.v1
Yap, T. A., Walton, M. I., Hunter, L.-J. K., Valenti, M. R., Brandon, A. D. H., Eve, P. D., Ruddle, R. R., Heaton, S. P., Henley, A. T., Pickard, L., et al. (2023) · doi:10.1158/1535-7163.c.6535195
Clinical Experiences with Drugs Targeting m TOR
Witzig, T. E. (2023) · Wiley eBooks · doi:10.1002/9781119819950.ch8
Gabrili, J. J. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2023.tde-06092023-152250
Etude du rôle des protéines QSOX1 et GABARAPL1 dans l'autophagie et le cancer
Poillet-Perez, L. (2015) · theses.fr (ABES) · doi:10.70675/1bbe1f61z8441z422ez8241z9a1eabddd38d
Li, Y., Zou, X., Feng, X., Xia, J., Wu, Z., & Ma, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-15125-2
“A significant aspect of this regulatory mechanism is mediated through its interaction with the mTOR, which helps adjust cellular functions according to the cell’s energy and nutrient status 25 .”
Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity
Santinon, F., Παπαδόπουλος, Θ., Berg, M. H., McCallum, P. A., Abraham, M. J., Gonçalves, C., Gupta, V., Gagnon, N., Wirasinghe, N., Chou, H., et al. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00476-4
“Consequently, its availability for eIF4F complex formation is subject to tight cellular control by the PI3K/Akt/ mTOR pathway [3]. eIF4E is phosphorylated on serine 209 exclusively by the MAP kinase interacting serine/ threonine kinase (MNK) 1 and 2 [4, 5] and dysregulated phosphorylation of eIF4E…”
Peterson, M. S. (2013) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-3468
“The rate of cell division is intimately linked with the rate of translation (143).”
BackgroundInfluentialHidden Treasures in RNA Universe: Post-Transcriptional Regulation in Cancer and Virus Infection
Zucko, D. (2023) · University of Minnesota Digital Conservancy (University of Minnesota)
Etude fonctionnelle de la protéine Metastatic lymph node 51 dans le métabolisme des ARN messagers
Daguenet, É. (2012) · theses.fr (ABES) · doi:10.70675/517e57fcz26aaz4d59z992bz393fb6281692
Metadata
- Authors
- Mamane, Y., Petroulakis, E., LeBacquer, O., & Sonenberg, N.
- Affiliations
- McGill University (CA)
- Corresponding author
- Sonenberg, N
- ORCID
- Sonenberg, N
- Venue
- Oncogene
- Published
- 2006-10-16
- Volume
- 25
- Issue
- 48
- Pages
- 6416-6422
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2165848665
- Cited by
- 607
- References
- 79
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 4 · 2023: 28 · 2022: 14 · 2021: 7 · 2020: 23 · 2019: 16 · 2018: 32 · 2017: 26 · 2016: 28 · 2015: 41 · 2014: 41 · 2013: 40 · 2012: 41
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mTOR, mRNA translation, translation initiation, PI3K/AKT/mTOR pathway, 4E-BP, S6K, cap-dependent translation, cancer therapy, nutrient signaling, cell growth
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Mammals, Models, Genetic, Neoplasms, Peptide Chain Initiation, Translational, Protein Kinases, Signal Transduction, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.